Загрузка...
Improved Clearance during Treatment of HPV-Positive Head and Neck Cancer through mTOR Inhibition
Human papillomavirus (HPV)-related head and neck squamous cell carcinoma (HNSCC) incidence is increasing at a near epidemic rate. We investigated whether the mammalian (or mechanistic) target of rapamycin (mTOR) inhibitor, rapamycin, can be used as a concurrent agent to standard-of-care cisplatin/ra...
Сохранить в:
| Главные авторы: | , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Neoplasia Press Inc.
2013
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3664994/ https://ncbi.nlm.nih.gov/pubmed/23730210 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|